Cited by 34Nanoparticle-Based Drug DeliveryMalaria Research and ControlAdvanced Drug Delivery Systems

Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin

Kumar, Sahil, Singh, Rajesh K., Sharma, Rajiv, Murthy, R.S.R., Bhardwaj, T.R.·2015·European Journal of Pharmaceutical Sciences

Abstract

Various polymer drug conjugates (13-16) such as primaquine and dihydroartemisinin conjugated 2-propoxy substituted polyphosphazenes (13), primaquine and dihydroartemisinin conjugated 4-acetamidophenoxy substituted polyphosphazenes (14), primaquine and dihydroartemisinin conjugated 4-formyl substituted polyphosphazenes (15) and primaquine and dihydroartemisinin conjugated 4-aminoethylbenzoate substituted polyphosphazenes (16) were synthesized using substituted polyphosphazenes as polymer and primaquine and dihydroartemisinin as combination antimalarial pharmacophores and formulated to nanoparticles to achieve novel controlled combined drug delivery approach for radical cure of malaria. The polymeric backbone was suitably substituted to impart different physicochemical properties. The polymer-drug conjugates were characterized by IR, (1)H NMR, (31)P NMR and their molecular weights were determined by Gel Permeation Chromatography. The thermal properties of the conjugates (13-16) were studied by DSC and TGA. The conjugates (13-16) were then formulated to nanoparticles formulations to increase their uptake by hepatocytes and to achieve targeted drug delivery. The nanoparticle formulations were characterized by Zeta Sizer and their morphology were studied by TEM (Transmission Electron Microscopy) imaging. The nanoparticles formulations exhibited biphasic in vitro drug release profile, the initial burst release followed by a sustained release owing to the non-fickian diffusion during first step release and fickian diffusion during second step release. In vivo antimalarial efficacy was tested using Plasmodium berghei (NK65 resistant strain) infected swiss albino mice at different doses. The combination therapy exhibited promising antimalarial efficacy at lower doses in comparison to the standard drug combination. Further, this combination therapy provided protection over 35days without any recrudescence, thus proving to be effective against resistant malaria. The study provides an alternative combination regimen found to be effective in the treatment of resistant malaria.

Integrity signals

Registry

Crossref · 10.1016/j.ejps.2014.09.023

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Polymer-drug conjugates of primaquine and dihydroartemisinin exhibited promising antimalarial efficacy in vivo against a resistant parasite strain.

    “The combination therapy exhibited promising antimalarial efficacy in vivo against a resistant parasite strain 113 .”

    From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [113]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kumar, S., Singh, R. K., Sharma, R., Murthy, R. S. R., & Bhardwaj, T. R.
Affiliations
Indo Soviet Friendship College of Pharmacy (IN)
Corresponding author
Kumar, Sahil
Venue
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2015-01
Volume
66
Pages
123-137
ISSN
0928-0987 (ISSN-L)
OpenAlex
W2010551919
Cited by
34
References
39
Citations by year
2026: 2 · 2025: 2 · 2023: 4 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 4
FWCI
1.26
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
Life Science Research Board (LSRB) of Defense Research and Development Organization (DRDO), New Delhi (India)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
polyphosphazenes, polymer-drug conjugates, primaquine, dihydroartemisinin, combination antimalarial therapy, nanoparticle drug delivery, controlled drug release, Plasmodium berghei, drug resistance, non-Fickian diffusion
MeSH terms
Animals, Antimalarials, Humans, Malaria, Organophosphorus Compounds, Plasmodium berghei, Polymers, Primaquine, Molecular Structure, Artemisinins, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review